Faeth Therapeutics files Form 8-K
Faeth Therapeutics filed a Form 8-K. The filing date is listed as October 27; the headline references October 23.
Related stories
Norwegian Cruise Line shares rise after raising full-year earnings outlook
Shares rose about 13% premarket after Norwegian Cruise Line raised its full-year earnings outlook, citing stronger-than-expected last-minute bookings and higher onboard spending.
M impact | EQUITY | Oct 29, 2026, 12:23 PM UTC
Federal Signal Reports Q3 Results
Federal Signal reported its third-quarter results.
M impact | EQUITY | Oct 29, 2026, 12:15 PM UTC
Coherus Reports 75% Tagmokitug Response Rate in First-Line ESCC
Coherus Oncology reported a 75% confirmed response rate among evaluable first-line ESCC patients, rising to 89% after the data cutoff. The company plans to expand the cohort.
M impact | EQUITY | Oct 29, 2026, 12:13 PM UTC
Mastercard Publishes Third-Quarter 2026 Earnings Release
Mastercard published its third-quarter 2026 earnings release.
M impact | EQUITY | Oct 29, 2026, 12:12 PM UTC
Bethel Automotive Safety Systems Q3 net profit rises 5.17% year over year
M impact | EQUITY | Oct 29, 2026, 12:12 PM UTC
US Equity Futures Edge Lower Before the Bell
US equity futures were edging lower before the bell Thursday.
M impact | EQUITY | Oct 29, 2026, 12:12 PM UTC